What's Next For Prothena Stock After A 9% Rise This Week?

The stock price of Prothena Corporation (NASDAQ: PRTA), a biotechnology company focused on treatment of diseases that involve protein misfolding or cell adhesion, has seen a 9% rise over the last five trading days, after the company announced that PRX004 phase 1 study results w

The stock price of Prothena Corporation (NASDAQ: PRTA), a biotechnology company focused on treatment of diseases that involve protein misfolding or cell adhesion, has seen a 9% rise over the last five trading days, after the company announced that PRX004 phase 1 study results w